Search filters

Filters
Clear All

Phase

  • 20
  • 28
  • 1
  • 27
  • 1
  • 20
  • 8
  • 252
  • 372
  • 175
  • 4
  • 23
  • 346

Found 373 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18-99 years
All genders
The main purpose of this study is to determine if certain genes, hormones, or other factors predict the risk of developing lung vessel disease in patients with liver disease and whether they determine outcome. Patients in need of a liver transplant evaluation or have portopulmonary hypertension or are suspected of …
 KEYMAKER-U02- substudy 02B
18-99 years
All genders
Phase 1
Patients from Penn Medicine's Abramson Cancer Center will be approached for participation.This sub-study is part of a larger research study that is testing experimental treatments for melanoma. Various study drugs will be tested in combination with pembrolizumab in this study. Treatment groups include: a) MK-7684 and pembrolizumab b) pembrolizumab alone …
18-99 years
All genders
This will be a prospective, observational, multicenter study. All implants will be placed in the maxilla or mandible for already established participants at Penn Dental Medicine. The patient will either have a temporary prosthesis placed (out of occlusion) immediately (during the same implant placement visit or within 48 hours) or …
 Seeking LGBTQ+ persons for a study on attitudes and beliefs regarding HIV vaccines
15-50 years
Male
We are interested in finding out more about LGBTQ+ individuals people’s beliefs and attitudes and beliefs regarding HIV vaccines and other health-related topics. Our study consists of 9 surveys over a 3-year period. These surveys may be completed online, at any location. Eligible participants will be paid upon the successful completion …
99 years and younger
All genders
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE. Up to 1200 subjects with intermediate-risk acute PE will be randomized. All subjects who sign informed consent and who meet all of the inclusion criteria and none …
 Mapping Muscle Specific Metabolism in Different Age Groups
18-80 years
Accepts healthy volunteer
All genders
The purpose of the study is to determine the changes in muscle metabolites by MRI before and after exercise.    The MRI will be performed while performing mild exercise of the calf muscle for 1-3 minutes.  We are actively recruiting adults between 18-30, 45-55 and 70-80.  Volunteers cannot have diabetes …
 Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301
18-99 years
All genders
Interventional
This is a Phase 3b, multicenter, open-label extension (OLE) study to evaluate the efficacy and safety of Nefecon treatment in patients with IgAN who have completed the Phase 3 Study Nef 301 and continue to be treated with a stable dose of RAS inhibitor therapy (ACEIs and/or ARBs). Patients who …
99 years and younger
All genders
To document the long-term safety and tolerability profile of osilodrostat in routine clinical practice over a 3 year follow up period in patients with endogenous Cushing's Syndrome. The study population is male and females 18 years or greater who are being treated with osilodrostat.The primary data source will be the …
99 years and younger
All genders
This is a prospective, randomized, controlled, multi-center, clinical trial to demonstrate use of the Nectero East System for stabilization of abdominal aortic aneurysms (AAA) with a maximum diameter of 3.5-5.0 cm. Subjects with AAA will be randomized to either the standard of care control group or the study treatment group …
18-99 years
Male
Phase 2
To evaluate safety of ultrahypofractionated proton therapy to the prostate and whole pelvis with HDR brachytherapy boost. The technique will be deemed safe if 10% of patients experience a CTCAE grade 3 or higher genitourinary or gastrointestinal toxicity cumulatively over the first year of treatment.To evaluate for multiple domains of …
61 - 70 of 373